ORBIMED ADVISORS LLC – Mereo BioPharma Group plc Transaction History
ORBIMED ADVISORS LLC portfolio value:
$9.13M
portfolio value
ORBIMED ADVISORS LLC quarter portfolio value change:
-23.12%
quarter
Mereo BioPharma Group plc 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | Increase | +9.21% | 894.1K shares | -1.74M | $0.86 | 10.60M |
Q2 2022 | share | Decrease | -43.75% | -7.55M shares | -8.45M | $1.12 | 9.71M |
Q1 2022 | share | 0.00% | 0 shares | -8.28M | $1.12 | 17.26M | |
Q4 2021 | share | 0.00% | 0 shares | -14.15M | $1.61 | 17.26M | |
Q3 2021 | share | 0.00% | 0 shares | -12.94M | $2.42 | 17.26M | |
Q2 2021 | share | Increase | 0.00% | 1 shares | -3.45M | $3.17 | 17.26M |
Q1 2021 | share | Increase | +24.96% | 3.44M shares | 8.72M | $3.37 | 17.26M |
Q4 2020 | share | Increase | 0.00% | 13.81M shares | 49.46M | $3.58 | 13.81M |